Stocks
Charles River Laboratories International, Inc.CRL
NYSEHealthcareBiotechnology$155.46+1.83%
A leading provider of essential research tools and integrated support services for drug discovery and development, Charles River Laboratories serves pharmaceutical and biotechnology clients globally. Investors monitor its performance as a bellwether for preclinical contract research demand and biopharma R&D spending trends.
Market Cap: $7.7B52W Range: $91.86 – $228.88
Congressional Interest in Charles River Laboratories International, Inc. (CRL)
3 members of Congress have disclosed 11 trades in Charles River Laboratories International, Inc. (CRL), a Healthcare company. The buy/sell breakdown shows 8 purchases versus 3 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
11
Unique Politicians
3
Buys
8
Sells
3
Who in Congress Is Trading CRL?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2009-11-12 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2009-09-01 | MICHAEL T. MCCAUL | sell | $1K – $15K |